Bio-Rad Laboratories, Inc. (BIO) vs DENTSPLY SIRONA Inc. (XRAY)
BIO leads on 7 of 13 compared metrics.
A side-by-side comparison of Bio-Rad Laboratories, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BIO vs XRAY
growth of $100 · last 30yBIO +1488.6%XRAY +44.6%BIO compounded faster
Log scale — wide-divergence pair
BIO XRAY
BIO vs XRAY: by the numbers
- •BIO is the larger company ($7.73B vs $2.02B market cap).
- •BIO is profitable (6.52% net margin) while XRAY runs a net loss (-17.06%).
- •XRAY grew revenue faster over the past five years (1.12% vs -0.84% CAGR).
- •XRAY pays a dividend (4.76% yield) while BIO does not currently pay one.
Which is better, BIO or XRAY?
Metric tally: BIO 7 · XRAY 6It depends on what you're optimizing for:
GrowthXRAY(faster 5Y revenue CAGR)
QualityXRAY(higher ROIC)
Valuation
| Metric | BIO | XRAY |
|---|---|---|
| P/E ratio | 47.11 | — |
| Forward P/E | 28.69 | 7.11● |
| P/S ratio | 2.98 | 0.55● |
| P/B ratio | 1.13● | 1.53 |
| EV / EBITDA | 18.27 | — |
| FCF yield | 4.63% | 5.16%● |
Profitability
| Metric | BIO | XRAY |
|---|---|---|
| Gross margin | 51.87%● | 48.93% |
| Operating margin | 9.25%● | 5.87% |
| Net margin | 6.52%● | -17.06% |
| ROE | 2.46%● | -47.65% |
| ROIC | 2.04% | 5.67%● |
Dividends
| Metric | BIO | XRAY |
|---|---|---|
| Dividend yield | — | 4.76% |
Growth (annualized)
| Metric | BIO | XRAY |
|---|---|---|
| Revenue CAGR (5Y) | -0.84% | 1.12%● |
| EPS CAGR (5Y) | -26.27% | -0.93%● |
| FCF CAGR (5Y) | -7.57%● | -29.96% |
| Total return CAGR (5Y) | -13.82%● | -29.72% |
Frequently asked
- Which is better, BIO or XRAY?
- It depends on your goal. growth: XRAY (faster 5Y revenue CAGR); quality: XRAY (higher ROIC). Across all compared metrics, BIO leads 7 to 6.
- Which has grown faster, BIO or XRAY?
- Over the past five years, XRAY grew revenue faster — BIO at a -0.84% CAGR versus XRAY at 1.12%.
- Does BIO or XRAY pay a bigger dividend?
- XRAY pays a dividend (4.76% yield) while BIO does not currently pay one.
- Is BIO or XRAY more profitable?
- BIO runs the higher net margin — BIO at 6.52% versus XRAY at -17.06%.
- Which has been the better investment, BIO or XRAY?
- Over the past 10-year, BIO delivered the higher annualized total return — BIO at 6.91% versus XRAY at -15.61%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratioDENTSPLY SIRONA P/E ratioBio-Rad Laboratories dividend yieldDENTSPLY SIRONA dividend yieldBio-Rad Laboratories ROEDENTSPLY SIRONA ROEBio-Rad Laboratories operating marginDENTSPLY SIRONA operating marginBio-Rad Laboratories revenue growthDENTSPLY SIRONA revenue growthBio-Rad Laboratories free cash flowDENTSPLY SIRONA free cash flow
Bio-Rad Laboratories & DENTSPLY SIRONA appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.